Back

Early experience Impella percutaneous ventricular assist device complications from a multi-ethic asian cohort

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure 4 Nonpharmacological Treatment HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Hwei Sung Ling

Swinburne University of Technology Sarawak Campus, Kuching (Malaysia)

6 More presentations in this session

Presentation thumbnail
Description of the profile of the patient with heart failure depending on the discharge service and the possible optimization of treatment with SGLT2i in a retrospective cohort from 2021 to 2022
Doctor C. Bonanad Lozano (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
The effect of diuretic-based, decongestion protocols vs standard of care on decongestion and clinical outcomes of patients admitted with acute heart failure and congestion
Doctor C. Kapelios (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Comparing using a digital weight tracker app versus the traditional logbook, for daily weight monitoring as part of heart failure self-care, in patients with cognitive impairment
Ms N. Caples (Waterford, IE)
Abstract Slides Video
Presentation thumbnail
Beyond circulatory support: VA-ECMO in acute heart failure and bridge to transplant
Doctor M. Leite (Porto, PT)
Abstract Slides Video
Presentation thumbnail
High-flow nasal cannula versus conventional oxygen therapy in acute heart failure: a meta-analysis
Doctor J. Mesquita Guimaraes (Coimbra, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in acute heart failure 4

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Safety and mid-term outcomes of impella compared to intra-aortic balloon pumping in patients who required mechanical cardiac support
thumbnail
Congress Presentation
Lowest complications and total mortality with Intra-aortic balloon pump vs Impella despite adjustment for 54 variable or hospital types in patients with cardiogenic shock
thumbnail
Congress Presentation
Comparison of efficacy and safety between impella and standard care in cardiogenic shock due to acute myocardial infarction: a systematic review

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources